NasdaqGS:ICLRLife Sciences
ICON (ICLR) Valuation Check After an Earnings Beat, Bookings Turnaround and R&D Recovery Hopes
ICON (NasdaqGS:ICLR) is back in focus after beating on revenue and earnings, while bookings growth finally turned a corner, hinting that the toughest stretch of the healthcare R&D downturn may be easing.
See our latest analysis for ICON.
The upbeat earnings and improving bookings have helped ICON stage a sharp rebound, with a roughly 15% 30 day share price return. However, the year to date share price return and 1 year total shareholder return are still negative, suggesting momentum is only...